BDRON 250 mg Tablets Abiraterone 250 mg Tablets by BDR Pharmaceuticals contain abiraterone acetate, a hormone-targeting medicine used to treat advanced and metastatic prostate cancer. It works by blocking an enzyme responsible for producing androgens (male hormones), which can stimulate the growth of prostate cancer cells. By lowering hormone levels, the medicine helps slow the progression of the disease and supports more effective long-term treatment. It is commonly prescribed together with prednisone or prednisolone.

Effects & Benefits Helps slow the growth of prostate cancer cells. Reduces the production of male hormones that fuel cancer growth. Supports the treatment of advanced and metastatic prostate cancer. May help delay the spread and progression of the disease. Can improve treatment response when used alongside other prescribed therapies. Supports long-term disease management under specialist medical care. Possible Side Effects

Like all medicines, Abiraterone 250 mg Tablets may cause side effects, although not everyone experiences them